Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2017 1
2018 3
2020 1
2021 4
2022 11
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Natural History of MYH7-Related Dilated Cardiomyopathy.
de Frutos F, Ochoa JP, Navarro-Peñalver M, Baas A, Bjerre JV, Zorio E, Méndez I, Lorca R, Verdonschot JAJ, García-Granja PE, Bilinska Z, Fatkin D, Fuentes-Cañamero ME, García-Pinilla JM, García-Álvarez MI, Girolami F, Barriales-Villa R, Díez-López C, Lopes LR, Wahbi K, García-Álvarez A, Rodríguez-Sánchez I, Rekondo-Olaetxea J, Rodríguez-Palomares JF, Gallego-Delgado M, Meder B, Kubanek M, Hansen FG, Restrepo-Córdoba MA, Palomino-Doza J, Ruiz-Guerrero L, Sarquella-Brugada G, Perez-Perez AJ, Bermúdez-Jiménez FJ, Ripoll-Vera T, Rasmussen TB, Jansen M, Sabater-Molina M, Elliot PM, Garcia-Pavia P; European Genetic Cardiomyopathies Initiative Investigators. de Frutos F, et al. J Am Coll Cardiol. 2022 Oct 11;80(15):1447-1461. doi: 10.1016/j.jacc.2022.07.023. Epub 2022 Aug 22. J Am Coll Cardiol. 2022. PMID: 36007715 Free article.
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators (see Appendix). Palau P, et al. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35604416 Free article. Clinical Trial.
Rivaroxaban Inappropriate Dosage Predictor Factors Using The Ckd-Epi Equation.
Pérez Cabeza AI, Górriz JL, Bravo Marqués R, Chinchurreta Capote PA, López Tejero S, González Correa JA, Mesa Prado FE, Valle Alberca A, Ruiz Mateas F. Pérez Cabeza AI, et al. Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):216-218. doi: 10.1016/j.nefro.2020.04.016. Epub 2020 Aug 18. Nefrologia (Engl Ed). 2021. PMID: 32819726 Free article. English, Spanish. No abstract available.
Predictor factors of inappropriate rivaroxaban dosage using the Ckd-Epi equation.
Pérez Cabeza AI, Górriz JL, Bravo Marqués R, Chinchurreta Capote PA, López Tejero S, González Correa JA, Mesa Prado FE, Valle Alberca A, Ruiz Mateas F. Pérez Cabeza AI, et al. Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):216-218. doi: 10.1016/j.nefroe.2021.04.002. Epub 2021 May 15. Nefrologia (Engl Ed). 2021. PMID: 36165386 Free article. No abstract available.
Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient settings.
Piserra López-Fernández De Heredia A, Ruiz Ortiz M, Pérez Cabeza AI, Díaz Expósito A, Fernández Valenzuela MI, Carrillo Bailén M, Alarcón De La Lastra Cubiles I, Moreno Vega A, Zalabardo Aguilar M, Chaparro Muñoz M, García Manrique T, Torres Llergo J, Ortega Granados AL, Sánchez Fernández JJ, Calvete Cadenas J, Mesa Rubio D; Working Groups of Atrial Fibrillation and Cardio-Onco-Hematology of the Andalusian Society of Cardiology. Piserra López-Fernández De Heredia A, et al. Among authors: perez cabeza ai. Curr Probl Cardiol. 2024 Feb;49(2):102239. doi: 10.1016/j.cpcardiol.2023.102239. Epub 2023 Dec 5. Curr Probl Cardiol. 2024. PMID: 38056515 Review.
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment.
Rivera-Caravaca JM, Anguita Sanchez M, Sanmartín Fernández M, Rafols C, Barón-Esquivias G, Arribas Ynsaurriaga F, Freixa-Pamias R, Lekuona Goya I, Vázquez Rodríguez JM, Pérez-Cabeza AI, Cosín-Sales J, Ureña Montilla I, Álvarez-Vieitez Blanco A, Marín F. Rivera-Caravaca JM, et al. Among authors: perez cabeza ai. Am J Cardiol. 2023 Sep 15;203:122-127. doi: 10.1016/j.amjcard.2023.06.105. Epub 2023 Jul 22. Am J Cardiol. 2023. PMID: 37487406 Free article.
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.
Marín F, Fernández MS, Barón-Esquivias G, Barrios V, Lekuona I, Pérez-Cabeza AI, Masjuan J, Del Vigo ER, Vázquez Rodríguez JM, Freixa-Pamias R, Schilling VR, Arribas F, Priu CR, Sánchez MA. Marín F, et al. Among authors: perez cabeza ai. J Comp Eff Res. 2023 Mar;12(3):e220049. doi: 10.57264/cer-2022-0049. Epub 2023 Feb 7. J Comp Eff Res. 2023. PMID: 36749006 Free PMC article.
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
Marin F, Fernández MS, Lekuona I, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Pérez-Cabeza AI, Schilling VR, Vázquez Rodríguez JM, Priu CR, Sánchez MA. Marin F, et al. Among authors: perez cabeza ai. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. J Comp Eff Res. 2022. PMID: 36148923 Free article.
22 results